Therefore, studying the structural changes of bisecting GlcNAc and the aberrant expression of GnT-III will aid in advancing our understanding of its role in RCC development and provide a theoretical basis for the search for potential biomarkers that can be used in the diagnosis and treatment of RCC. This evidence concerns the gene MGAT3 and renal cell adenocarcinoma.